Hjem › Kreft (alle typer) › New York › New York City
Kliniske studier for Kreft (alle typer) i New York City, NY
109 studier for Kreft (alle typer) søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
PediRISE Feasibility
Rekrutterer
- Columbia University Medical Center, New York
Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer
Rekrutterer
- Memorial Sloan Kettering Cancer Center, New York
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekruttererFase 1
- Columbia University - Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
RekruttererFase 3
- Memorial Sloan Kettering Cancer Center, New York
Registry Study for Radiation Therapy Outcomes
RekruttererObservasjonsstudie
- New York Proton Center, New York
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RekruttererObservasjonsstudie
- NYU Grossman School of Medicine, New York
A Study of Music Therapy for Anxiety in People With Cancer
Rekrutterer
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RekruttererFase 3
- Investigative Site, New York
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
RekruttererFase 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
RekruttererFase 2
- Rockefeller Outpatient Pavilion ( Site 0002), New York
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
RekruttererFase 1
- NYU Langone Health, New York
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center ( Site 4010), New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
- NYU Langone Medical Center, New York
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruttererFase 2/3
- Icahn School of Medicine at Mount Sinai, New York
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RekruttererFase 3
- NYU Langone Medical Center, New York
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Rekrutterer
- Columbia University Irving Medical Center, New York
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Manhattan Eye, Ear, and Throat Hospital, New York
- Staten Island University Hospital, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Prospective Study to Assess a Diagnostic Aid for Cancer
RekruttererObservasjonsstudie
- Memorial Sloan Kettering Cancer Center, New York
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
RekruttererObservasjonsstudie
- City College of New York (Data Collection AND Data Analysis), New York
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
- Memorial Sloan Kettering Cancer Center, New York
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- New York University - Langone Medical Center - The Center for Musculoskeletal Care, New York
- Weill Cornell Medicine / New York Presbyterian Hospital, New York
- Icahn School Of Medicine At Mount Sinai, New York
- og 2 flere
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center ( Site 3010), New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- NYU Langone Health, New York
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RekruttererFase 1/2
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- og 1 flere
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
Psychotherapy Intervention for Latinos With Advanced Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Cancer Center, New York
- Ralph Lauren Center for Cancer Care and Prevention, New York
Psychotherapy Intervention for Latinos With Adv Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- MSK at Ralph Lauren, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Laura and Isaac Perlmutter Cancer Center, New York
- Manhattan Eye, Ear and Throat Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
RekruttererFase 2
- Laura and Isaac Perlmutter Cancer Center, New York
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RekruttererObservasjonsstudie
- Mount Sinai Hospital, New York
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- Manhattan Hematology /Oncology Associates, New York
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C (NY), New York
Lurbinectedin in FET-Fused Tumors
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Weill Cornell Medical College (Data or Specimen Analysis Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of ARC-02 in B-cell NHL
RekruttererFase 1
- NYU Langone, New York
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai Hospital, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- og 2 flere
A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare
RekruttererObservasjonsstudie
- Memorial Sloan Kettering Cancer Center, New York
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RekruttererFase 3
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
RekruttererFrivillige helsepersonell ønskes velkommen
- NYP/Weill Cornell Medical Center, New York
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Rekrutterer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
RekruttererFase 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center, New York
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Mount Sinai Chelsea, New York
- Bellevue Hospital Center, New York
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- og 3 flere
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Cancer Center, New York
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)
RekruttererFrivillige helsepersonell ønskes velkommen
- Columbia University Irving Medical Center, New York
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruttererFase 1/2
- Mount Sinai - The Tisch Cancer Institute /ID# 272470, New York
- Weill Cornell Medical College /ID# 272517, New York
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- NYU Langone Health-Perlmutter Cancer Center, New York
- Memorial Sloan Kettering Cancer Center - Melanoma & Immunotherapeutics, New York
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Mt Sinai /ID# 251166, New York
- Memorial Sloan Kettering Cancer Center-Koch Center /ID# 251167, New York
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
RekruttererFase 1
- Local Institution - 0011, New York
- Memorial Sloan Kettering Cancer Center, New York
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekruttererFase 1
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruttererFase 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Evaluation of Grief Therapy Approaches for Bereaved Parents
Rekrutterer
- Memorial Sloan Kettering Cancer Center, New York
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruttererFase 1/2
- New York University Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RekruttererFase 1
- GSK Investigational Site, New York
A Multi Center Study of Sexual Toxicities After Radiotherapy
RekruttererObservasjonsstudie
- Icahn School of Medicine at Mount Sinai, New York
Childhood Cancer Survivor Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Memorial-Sloan Kettering Cancer Center, New York
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- VA NY Harbor Healthcare System, New York, NY, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- NYU Langone Medical Center, New York
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
RekruttererFase 1/2
- Weill Medical College of Cornell University, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekruttererFase 1
- Research Site, New York
- Research Site, New York
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruttererFase 1
- NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
RekruttererFase 1/2
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
RekruttererFase 1/2
- Lenox Hill Brain Tumor Center, New York
A Study of Herbal Supplements in Cancer Survivors With Constipation
Rekrutterer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Laura and Isaac Perlmutter Cancer Center / NYU Langone Health, New York
- Columbia University Medical Center, New York
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
RekruttererFase 2
- Perlmutter Cancer Center - 34th Street, New York
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
RekruttererFase 2
- Weill Cornell Medicine, New York
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RekruttererFase 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Columbia University Medical Center, New York
- Memorial Slone Kettering Cancer Center, New York
A New Psychotherapy Intervention for Older Cancer Patients
Rekrutterer
- Memorial Sloan Kettering Cancer Center, New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
Rekrutterer
- The New York Proton Center, New York
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
RekruttererObservasjonsstudie
- Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment Center, New York
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Universal Genetic Testing for Cancer Risk Reduction
RekruttererFrivillige helsepersonell ønskes velkommen
- NYU Langone Health, New York
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RekruttererFase 1/2
- Columbia University Irving Medical Center, New York
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers
Rekrutterer
- NYU Langone Health, New York
Food and Microbiome Longitudinal Investigation (FAMiLI)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- New York University School of Medicine, New York
Primary Tumor Research and Outcomes Network
RekruttererObservasjonsstudie
- Memorial Sloan Kettering Cancer Center, New York
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- Icahn School of Medicine at Mount Sinai, New York
Upright MRI for Prostate Cancer Screening
RekruttererObservasjonsstudie
- Icahn School of Medicine at Mount Sinai, New York
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RekruttererFase 1
- Ichan School of Medicine at Mount Sinai, New York
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Cancer Center, New York
Cryopreservation of Ovarian Tissue
Rekrutterer
- Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, New York
An Acupuncture Study for Cancer Survivors With Joint Pain
RekruttererFrivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Rekrutterer
- Columbia University Medical Center, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- NYU Langone Health, New York
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Weill Cornell Medicine-New York-Presbyterian Hospital, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
RekruttererObservasjonsstudie
- Icahn School of Medicine at Mount Sinai, New York
Personalized Models for Cancer Research
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- New York Stem Cell Foundation Research Institute, New York
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekruttererFase 1/2
- NYU Langone Health, New York
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
- St. Louis, MO46 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
- Hjertesvikt51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.